ArticleFrontiers in immunology2022

Homologous recombination repair gene mutations as a predictive biomarker for immunotherapy in patients with advanced melanoma.

Zhixuan You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.